|By PR Newswire||
|September 2, 2014 11:23 AM EDT||
BETHLEHEM, Pa. and AUSTIN, Texas, Sept. 2, 2014 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) and RyMed Technologies, LLC announced today that they have entered into a long-term distribution agreement for the InVision-Plus® Neutral IV Connector.
"The InVision-Plus Neutral IV Connector with Neutral Advantage Technology is designed to inhibit migration of bacteria into the fluid pathway, potentially improving patient outcomes, and enhancing clinician safety," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun. "This agreement will complement B.Braun's current needleless connector portfolio offering to include a neutral displacement line of products," added Sutton.
The InVision-Plus Neutral IV Connector provides a priming volume of 0.027 mL. RyMed's InVision-Plus platform of products provide a 10-point standard of features.
"We are extremely pleased to enter into this agreement with B.Braun, one of the finest companies in IV fluid delivery. RyMed first introduced neutral displacement technology to the market in 2004, and with this agreement, we will be able to offer the InVision-Plus System to a broader audience via B.Braun's customers and GPO contracts," said Dana Ryan, President & CEO of RyMed Technologies, LLC.
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com
About RyMed Technologies, LLC
RyMed Technologies, LLC specializes in the development and marketing of innovative safety products in the field of intravenous catheter care and maintenance. The company's products are designed to help reduce catheter-related bloodstream infections (CR-BSIs) and intraluminal thrombotic catheter occlusions associated with vascular access. More than 10 years of research and development have gone into InVision-Plus®.
The company is headquartered in Franklin, TN. For more information, call (512) 301-7334 or access www.rymedtech.com.
CMC Consulting Group advised RyMed in the transaction.
SOURCE B. Braun Medical Inc.
Jan. 21, 2017 05:30 AM EST Reads: 3,549
Jan. 21, 2017 05:00 AM EST Reads: 2,996
Jan. 21, 2017 05:00 AM EST Reads: 4,012
Jan. 21, 2017 03:45 AM EST Reads: 1,985
Jan. 21, 2017 02:30 AM EST Reads: 5,041
Jan. 21, 2017 02:30 AM EST Reads: 6,109
Jan. 21, 2017 02:15 AM EST Reads: 5,358
Jan. 21, 2017 02:00 AM EST Reads: 5,815
Jan. 21, 2017 01:30 AM EST Reads: 6,566
Jan. 21, 2017 01:15 AM EST Reads: 4,903
Jan. 21, 2017 01:15 AM EST Reads: 5,052
Jan. 21, 2017 01:15 AM EST Reads: 2,886
Jan. 21, 2017 12:30 AM EST Reads: 4,574
Jan. 21, 2017 12:15 AM EST Reads: 6,375
Containers have changed the mind of IT in DevOps. They enable developers to work with dev, test, stage and production environments identically. Containers provide the right abstraction for microservices and many cloud platforms have integrated them into deployment pipelines. DevOps and Containers together help companies to achieve their business goals faster and more effectively. In his session at DevOps Summit, Ruslan Synytsky, CEO and Co-founder of Jelastic, reviewed the current landscape of D...
Jan. 21, 2017 12:00 AM EST Reads: 5,109